IP Verse

Boehringer Ingelheim Pharma & Cokg competitive analysis

Loading summary...

Latest patents of Boehringer Ingelheim Pharma & Cokg opposed by its competitors

Explore Boehringer Ingelheim Pharma & Cokg's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP1830843
Nov 7, 2012Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases1

Latest publications and patents of Boehringer Ingelheim Pharma & Cokg New

Explore the latest publications and patents granted to Boehringer Ingelheim Pharma & Cokg, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Boehringer Ingelheim Pharma & Cokg

EP1830843
Nov 7, 2012Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic DiseasesOpposition Rejected

Latest PTAB cases involving Boehringer Ingelheim Pharma & Cokg

Discover the latest PTAB cases involving Boehringer Ingelheim Pharma & Cokg, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Pharma & Cokg with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BOEHRINGER INGELHEIM PHARMA & COKG - 1 - -
SANDOZ1181619 -